PUBLISHER: The Business Research Company | PRODUCT CODE: 1826970
PUBLISHER: The Business Research Company | PRODUCT CODE: 1826970
Periodontal disease treatment encompasses medical procedures and interventions designed to prevent, manage, and reverse the effects of periodontal diseases, which impact the gums and surrounding tooth structures. The primary goal is to reduce inflammation, prevent tooth loss, and enhance overall oral health.
The main types of periodontal disease treatments include gingivitis, chronic periodontal disease, aggressive periodontal disease, and other variations. Gingivitis is characterized by gum swelling, redness, and irritation caused by plaque buildup around the teeth. Treatment options include non-surgical procedures, scaling and root planing, medication, surgical treatments such as flap surgery and bone grafts, and other therapeutic approaches. These treatments are administered through various routes, including oral and injectable methods, and are distributed through hospital pharmacies, retail pharmacies, and other channels. They serve a range of end-users, including hospitals, clinics, dental clinics, dental academic and research institutes, and other healthcare providers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The periodontal disease treatment market research report is one of a series of new reports from The Business Research Company that provides periodontal disease treatment market statistics, including the periodontal disease treatment industry global market size, regional shares, competitors with the periodontal disease treatment market share, detailed periodontal disease treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the periodontal disease treatment industry. This periodontal disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The periodontal disease treatment market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the rise in the geriatric population, the increase in dental care infrastructures, the increase in chronic and aggressive periodontitis illness, the increase in the risk of periodontal diseases, and the increase in the number of periodontitis patients with a sedentary lifestyle.
The periodontal disease treatment market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for better oral hygiene, rising cases of edentulism, a rising number of periodontal therapeutic procedures, increasing levels of advertising expenses, and growing medical and dental tourism in developing countries. Major trends in the forecast period include technological innovations, adopting innovative technologies, advanced periodontal treatment technologies, artificial intelligence in diagnosis, and advanced periodontal flap surgery.
The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to increase U.S. dental care costs by driving up prices of periodontal scalers and bone graft materials sourced from Brazil and Italy, exacerbating out-of-pocket expenses for patients and limiting access to advanced gum disease treatments. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of oral health disorders is expected to drive the growth of the periodontal disease treatment market. These disorders affect the teeth, gums, and mouth, including conditions such as cavities, gum disease, oral infections, and oral cancer. Factors contributing to the rise in oral health disorders include poor oral hygiene, unhealthy diets, tobacco and alcohol use, aging populations, and limited access to dental care. Periodontal disease treatment helps manage and prevent these issues by addressing gum infections, inflammation, and bone loss. For example, in October 2024, the Australian Institute of Health and Welfare (AIHW), a government agency in Australia, reported that poor oral health, including tooth decay, gum disease, and tooth loss, affected a significant number of Australian children and adults, accounting for 4.5% of the overall non-fatal disease burden in 2022. As a result, the increasing incidence of oral health disorders is expected to fuel the growth of the periodontal disease treatment market.
Leading companies in the periodontal disease treatment market are developing innovative solutions such as dental gel to promote bone regeneration, improve treatment accessibility, reduce invasiveness, and provide more effective and patient-friendly alternatives to traditional periodontal treatments. Dental gel is a medicated oral product containing antibacterial, anti-inflammatory, or fluoride agents designed to prevent cavities, reduce gum disease, and relieve oral discomfort. In October 2024, Oral Biolife Inc., a US-based biotechnology company, introduced Ambrilux Dental Gel, a breakthrough treatment aimed at stimulating bone regeneration in cases of periodontal disease. Large animal trials demonstrated promising results, with 100% of Beagle dogs treated showing increased bone growth. This innovation has the potential to transform non-invasive dental care for both humans and companion animals, addressing a critical medical need.
In March 2023, Intermed Inc., a US-based healthcare technology management company, acquired Perio Protect for an undisclosed amount. This acquisition aims to expand Intermed's dental care solutions by integrating Perio Protect's periodontal tray treatment technology, strengthening its market position, enhancing its ability to offer comprehensive dental treatments from prevention to restoration, and unlocking new growth opportunities in the U.S. and Canadian markets. Perio Protect, a US-based medical equipment manufacturer, specializes in designing and producing custom trays for the treatment of periodontal disease.
Major players in the periodontal disease treatment market are Bausch Health Companies Inc, DENTSPLY SIRONA Inc., Straumann AG, Sunstar Suisse S.A, NovaBone Products LLC, Nakanishi Inc., Brasseler USA, Geistlich Pharma AG, BIOLASE Inc., Bien-Air Dental, Convergent Dental Inc., Carl Martin GmbH, Karl Schumacher, Yoshida Dental MFG. Co. Ltd., Botiss Biomaterials GmbH, Millennium Dental Technologies Inc., PreXion Inc., AMD Lasers Inc., Steris Healthcare Pvt Ltd, Perio Protect, and Deppeler SA.
North America was the largest region in the periodontal disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in periodontal disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the periodontal disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The periodontal disease treatment market consists of revenues earned by entities by providing services such as professional dental cleanings, scaling and root planing, antibiotic therapy, surgical interventions for severe cases, laser therapy for gum restoration, and ongoing maintenance to prevent disease progression. The market value includes the value of related goods sold by the service provider or included within the service offering. The periodontal disease treatment market also includes sales of antiseptic mouthwashes, scaling and root planing kits, laser therapy devices, and diagnostic tools & devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values generated by organizations in the specified geography within the market, irrespective of where they are produced. They do not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Periodontal Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on periodontal disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for periodontal disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The periodontal disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.